Get started
Author

Hsiao‐Wang Chen

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer
2014 · Gottfried E. Konecny, Chen Wang, et al. · JNCI Journal of the National Cancer Institute · 400
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells
2015 · Diego Ploper, Vincent F. Taelman, et al. · Proceedings of the National Academy of Sciences · 228
PDF
Estrogen receptor signaling pathways in human non-small cell lung cancer
2007 · Diana C. Márquez-Garbán, Hsiao-Wang Chen, et al. · Steroids · 217
Analysis of the Steps Involved in Dengue Virus Entry into Host Cells
1999 · Shan-Ling Hung, Pei-Lun Lee, et al. · Virology · 178
PDF
WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors
2014 · Jamie N. Anastas, Rima M. Kulikauskas, et al. · Journal of Clinical Investigation · 176
PDF
Targeting Aromatase and Estrogen Signaling in Human Non‐Small Cell Lung Cancer
2009 · Diana C. Márquez‐Garbán, Hsiao‐Wang Chen, et al. · Annals of the New York Academy of Sciences · 125
Estrogen receptors in membrane lipid rafts and signal transduction in breast cancer
2006 · Diana C. Márquez, Hsiao-Wang Chen, et al. · Molecular and Cellular Endocrinology · 109
PD-0332991, a potent and selective inhibitor of cyclin-dependent kinase 4/6, demonstrates inhibition of proliferation in renal cell carcinoma at nanomolar concentrations and molecular markers predict for sensitivity.
2013 · Joshua E Logan, Nikayeh Mostofizadeh, et al. · PubMed · 101
Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization
2010 · William D. Tap, Fritz C. Eilber, et al. · Genes Chromosomes and Cancer · 98
Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer
2011 · Diana C. Marquez-Garban, Vei Mah, et al. · Steroids · 88
Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures
2016 · Boris Winterhoff, Habib Hamidi, et al. · Gynecologic Oncology · 69
Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy
2019 · Diana C. Márquez-Garbán, Gang Deng, et al. · The Journal of Steroid Biochemistry and Molecular Biology · 66
Pathologic and molecular responses to neoadjuvant trastuzumab and/or lapatinib from a phase II randomized trial in HER2-positive breast cancer (TRIO-US B07)
2020 · Sara A. Hurvitz, Jennifer L. Caswell-Jin, et al. · Nature Communications · 62
PDF
Structure-Function Analysis of Yeast mRNA Cap Methyltransferase and High-Copy Suppression of Conditional Mutants by AdoMet Synthase and the Ubiquitin Conjugating Enzyme Cdc34p
2000 · Beate Schwer, Nayanendu Saha, et al. · Genetics · 54
Proteasome ubiquitin receptor PSMD4 is an amplification target in breast cancer and may predict sensitivity to PARPi
2017 · Marlena S. Fejzo, Lee Anderson, et al. · Genes Chromosomes and Cancer · 33
Squalamine blocks tumor-associated angiogenesis and growth of human breast cancer cells with or without HER-2/neu overexpression
2019 · Diana C. Márquez-Garbán, Manuel Gorrín-Rivas, et al. · Cancer Letters · 27
Analysis in epithelial ovarian cancer identifies KANSL1 as a biomarker and target gene for immune response and HDAC inhibition
2020 · Marlena S. Fejzo, Hsiao-Wang Chen, et al. · Gynecologic Oncology · 26
ADRM 1‐amplified metastasis gene in gastric cancer
2015 · Marlena S. Fejzo, Lee Anderson, et al. · Genes Chromosomes and Cancer · 25
MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer
2018 · Marina Koutsioumpa, Hsiao-Wang Chen, et al. · Molecular Cancer Therapeutics · 23
Association of PD-L1 expression by immunohistochemistry and gene microarray with molecular subtypes of ovarian tumors
2020 · Curtis David Chin, Charlene Marie Fares, et al. · Modern Pathology · 19
Analysis of herpes simplex virus entering into cells of oral origin
2002 · Shan-Ling Hung, Yi-Hui Wang, et al. · Virus Research · 14
Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer
2016 · Chen Wang, Boris J Winterhoff, et al. · British Journal of Cancer · 10
PDF
A phase II, multicenter, randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with carboplatin/paclitaxel as front-line therapy for optimally debulked primary ovarian cancer: The TRIO14 trial.
2014 · Gottfried E. Konecny, Paul Haluska, et al. · Journal of Clinical Oncology · 7
Prognostic relevance of gene signatures in high-grade serous ovarian carcinoma.
2013 · Gottfried E. Konecny, Chen Wang, et al. · Journal of Clinical Oncology · 3
612 Pd-0332991, an Inhibitor of Cyclin-dependent Kinase 4/6, Demonstrates Inhibition of Proliferation in Renal Cell Carcinoma at Nanomolar Concentrations and Molecular Markers Predict for Sensitivity
2013 · Joshua Logan, Nikayeh Mostofizadeh, et al. · The Journal of Urology · 3
Works count: 40
Citation count: 2,165
H-index: 19
I10-index: 22
Year
Topic
Type